Skip to main content

Wave Life Sciences, Inc.

WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001631574

In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Q2 2021 vs. Q1 2021

How the institutions holding Wave Life Sciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of WVE: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders10287−15
Shares38.3M37.0M−1.24M (−3.2%)
Value$214.8M$246.7M+$31.9M (+14.9%)

New holders (16)

Institutions that held Wave Life Sciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to WVE in Q2 2021
InstitutionSharesValue% of portfolio
683 Capital Management, LLC500,000$3.33M0.17%
Balyasny Asset Management LLC390,104$2.60M0.01%
Renaissance Technologies LLC87,120$580.0K0.00%
ExodusPoint Capital Management, LP67,178$447.0K0.01%
QS Investors, LLC66,200$441.0K0.01%
Vontobel Holding Ltd.33,568$224.0K0.00%
Cambridge Investment Research Advisors, Inc.16,000$107.0K0.00%
Parametric Portfolio Associates LLC15,457$103.0K0.00%
Invesco Ltd.12,547$84.0K0.00%
Dynamic Technology Lab Private Ltd11,679$78.0K0.01%
US Bancorp806$5.00K0.00%
Corsicana & Co.500$3.00K0.00%
Asset Dedication, LLC200$1.00K0.00%
CKW Financial Group150$1.00K0.00%
Parallel Advisors, LLC121$1.00K0.00%
Quadrant Capital Group LLC30$00.00%

Sold out (31)

Institutions that held Wave Life Sciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.